AMAkihiko Murata

Akihiko Murata

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Akihiko Murata has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Miya Yoshino

    Division of Immunology, Department of Molecular and Cellular Biology, School of Life Science, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan

    6 shared publications
  • Kazuki Okuyama

    Laboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan

    5 shared publications
  • Shin-Ichi Hayashi

    Division of Immunology, Department of Molecular and Cellular Biology, School of Life Science, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan

    5 shared publications
  • Mari Hikosaka

    Department of Stem Cell and Developmental Biology, Mie University Graduate School of Medicine, Tsu, Mie, Japan

    3 shared publications
  • Shin-Ichi Hayashi

    Department of Molecular and Cellular Biology, Division of Immunology, School of Life Science, Faculty of Medicine, Tottori University, Yonago, Tottori 683-8503, Japan

    3 shared publications
  • Hideo Yagita

    Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan

    2 shared publications

Latest Publications

  • Open Access

    Two patients with postoperative recurrence of pancreatic acinar cell carcinoma successfully treated by FOLFIRINOX

    by Takeyuki Sawano, Yutaka Umehara, Koji Shimaya, Masaki Munakata, Akihiko Murata, Kenichi Takahashi, Hidekachi Kurotaki, Kenichi Hakamada

    【症例1】29歳男性,膵癌疑いにて亜全胃温存膵頭十二指腸切除術,結腸右半切除術,上腸間膜静脈部分切除術施行.膵腺房細胞癌(T3N1aM0 Stage IIB)にて術後S-1療法を行ったが局所再発を認めた.nab-PTX+GEM療法を開始したが再発腫瘍増大を認め,mFOLFIRINOX療法開始.12コース施行後,再発腫瘍消失.術後44か月生存中.【症例2】69歳男性,膵神経内分泌腫瘍,膵腺房細胞癌疑いにて膵体尾部切除術施行.膵腺房細胞癌(T3N0M0 Stage IIA)にて術後S-1療法を行ったが多発肝転移,AFP上昇を認めた.nab-PTX+GEM療法を開始したが肝転移増大,AFP高値悪化を認め,mFOLFIRINOX療法開始.12コース施行後,肝転移消失,AFP基準値内に低下.術後19か月生存中.【結語】術後再発に対して,FOLFIRINOX療法により長期生存を期待し得る可能性が示唆された.


  • Kit-independent mast cell adhesion mediated by Notch

    by Akihiko Murata, Mari Hikosaka, Miya Yoshino, Lan Zhou, Shin-Ichi Hayashi

    Kit/CD117 plays a crucial role in the cell–cell and cell–matrix adhesion of mammalian mast cells (MCs); however, it is unclear whether other adhesion molecule(s) perform important roles in the adhesion of MCs. In the present study, we show a novel Kit-independent adhesion mechanism of mouse cultured MCs mediated by Notch family members. On stromal cells transduced with each Notch ligand gene, Kit and its signaling become dispensable for the entire adhesion process of MCs from tethering to spreading. The Notch-mediated spreading of adherent MCs involves the activation of signaling via phosphatidylinositol 3-kinases and mitogen-activated protein kinases, similar to Kit-mediated spreading. Despite the activation of the same signaling pathways, while Kit supports the adhesion and survival of MCs, Notch only supports adhesion. Thus, Notch family members are specialized adhesion molecules for MCs that effectively replace the adhesion function of Kit in order to support the interaction of MCs with the surrounding cellular microenvironments.

  • Open Access

    Correlation between cell aggregation and antibody production in IgE-producing plasma cells

    by Mari Hikosaka, Akihiko Murata, Miya Yoshino, Shin-Ichi Hayashi


  • Open Access

    Notch-Mediated Cell Adhesion

    by Akihiko Murata, Shin-Ichi Hayashi

    Notch family members are generally recognized as signaling molecules that control various cellular responses in metazoan organisms. Early fly studies and our mammalian studies demonstrated that Notch family members are also cell adhesion molecules; however, information on the physiological roles of this function and its origin is limited. In this review, we discuss the potential present and ancestral roles of Notch-mediated cell adhesion in order to explore its origin and the initial roles of Notch family members dating back to metazoan evolution. We hypothesize that Notch family members may have initially emerged as cell adhesion molecules in order to mediate multicellularity in the last common ancestor of metazoan organisms.


  • Open Access

    An Evolutionary-Conserved Function of Mammalian Notch Family Members as Cell Adhesion Molecules

    by Akihiko Murata, Miya Yoshino, Mari Hikosaka, Kazuki Okuyama, Lan Zhou, Seiji Sakano, Hideo Yagita, Shin-Ichi Hayashi

    Notch family members were first identified as cell adhesion molecules by cell aggregation assays in Drosophila studies. However, they are generally recognized as signaling molecules, and it was unclear if their adhesion function was restricted to Drosophila. We previously demonstrated that a mouse Notch ligand, Delta-like 1 (Dll1) functioned as a cell adhesion molecule. We here investigated whether this adhesion function was conserved in the diversified mammalian Notch ligands consisted of two families, Delta-like (Dll1, Dll3 and Dll4) and Jagged (Jag1 and Jag2). The forced expression of mouse Dll1, Dll4, Jag1, and Jag2, but not Dll3, on stromal cells induced the rapid and enhanced adhesion of cultured mast cells (MCs). This was attributed to the binding of Notch1 and Notch2 on MCs to each Notch ligand on the stromal cells themselves, and not the activation of Notch signaling. Notch receptor-ligand binding strongly supported the tethering of MCs to stromal cells, the first step of cell adhesion. However, the Jag2-mediated adhesion of MCs was weaker and unlike other ligands appeared to require additional factor(s) in addition to the receptor-ligand binding. Taken together, these results demonstrated that the function of cell adhesion was conserved in mammalian as well as Drosophila Notch family members. Since Notch receptor-ligand interaction plays important roles in a broad spectrum of biological processes ranging from embryogenesis to disorders, our finding will provide a new perspective on these issues from the aspect of cell adhesion.


  • Stochastic differentiation into an osteoclast lineage from cloned macrophage-like cells

    by Shin-Ichi Hayashi, Akihiko Murata, Kazuki Okuyama, Yuhki Shimoda, Mari Hikosaka, Hisataka Yasuda, Miya Yoshino

  • Open Access

    CCR7-independent transport of skin antigens occurs in the dermis

    by Miya Yoshino, Kazuki Okuyama, Akihiko Murata, Michio Tomura, Shin-Ichi Hayashi

    Under homeostatic conditions, skin DCs migrate to regional LNs transporting self-antigens (self-Ags). The transport of self-Ags is considered to be critical for maintaining peripheral tolerance. Although the chemokine receptor CCR7 potently induces the migration of skin DCs to regional LNs, Ccr7−/− (Ccr7-KO) mice do not show skin auto-immune diseases. To resolve this inconsistency, we examined Ccr7-KO epidermis- or dermis-hyperpigmented transgenic (Tg) mice, in which the transport of skin self-Ags is traceable by melanin granules (MGs). Under CCR7-deficient conditions, the transport of epidermal MGs to regional LNs was impaired at 7 weeks of age. However, epidermal MGs could be transported when they had accumulated in the dermis. Ccr7-KO-dermis-pigmented Tg mice confirmed the presence of CCR7-independent transport from the dermis. Compared with WT-dermis-pigmented Tg mice, the amount of transported melanin and number of MG-laden CD11c+ cells were both approximately 40% of the WT levels, while the number of MG-laden CD205+ or CD207+ cells decreased to about 10% in skin regional LNs of Ccr7-KO-dermis-pigmented Tg mice. Cell sorting highlighted the involvement of CD11c+ cells in the CCR7-independent transport. Here, we show that CCR7-independent transport of skin self-Ags occurs in the dermis. This system might contribute to the continuous transport of self-Ags, and maintain peripheral tolerance.


  • A checkpoint in B-lymphopoiesis related to Notch resistance

    by Kazuki Okuyama, Akihiko Murata, Tetsuo Sudo, Miya Yoshino, Shin-Ichi Hayashi


  • A Notch Ligand, Delta-Like 1 Functions As an Adhesion Molecule for Mast Cells

    by Akihiko Murata, Kazuki Okuyama, Seiji Sakano, Masahiro Kajiki, Tomohisa Hirata, Hideo Yagita, Juan Carlos Zúñiga-Pflücker, Kensuke Miyake, Sachiko Akashi-Takamura, Sawako Moriwaki, et al.

    Mast cells (MCs) accumulate in chronic inflammatory sites; however, it is not clear which adhesion molecules are involved in this process. Recently, the expression of Notch ligands was reported to be upregulated in inflammatory sites. Although Notch receptors are known as signaling molecules that can activate integrins, their contributions to the adhesion of MCs have not been studied. In this study, we demonstrated that mouse MCs efficiently adhered to stromal cells forced to express a Notch ligand, Delta-like 1 (Dll1). Surprisingly, the adhesion was a consequence of direct cell–cell interaction between MCs and Dll1-expressing stromal cells rather than activation of downstream effectors of Notch receptor(s)-Dll1. The adhesion of MCs to Dll1-expressing stromal cells remained even when the cell metabolism was arrested. The recognition was blocked only by inhibition of Notch receptor(s)–Dll1 interaction by addition of soluble DLL1, or mAbs against Dll1 or Notch2. Taken together, these results indicate that Notch receptor(s) and Dll1 directly promote the adhesion of MCs to stromal cells by acting as adhesion molecules. This appreciation that Notch receptor–ligand interactions have an adhesion function will provide an important clue to molecular basis of accumulation of MCs to inflammatory sites.